Imaging Intravenous Iron

Status Recruiting

Clinical Trial Summary

The aim of this study is to track where the iron goes in different tissues in the hours, days and weeks after an intravenous iron infusion. We will track iron in tissues using MRI relaxometry parameters R1/R2/R2* which are well established as accurate indicators of tissue iron content.

Clinical Trial Description

This is a prospective, observational, study exploring the kinetics of tissue iron uptake following intravenous iron infusion (Ferinject), received as part of standard clinical care in a group of iron-deficient patients. Participants will be recruited through the Iron Deficiency Management Service, part of the Oxford University Hospitals NHS Foundation Trust (OUHFT) . Participants will receive their intravenous iron infusion (Ferinject) as part of their standard clinical care by an NHS clinician. They will undergo all the study MRI scans and additional study procedures at the Oxford Centre for Clinical Magnetic Resonance Research (OCMR), which is based at the John Radcliffe Hospital and is part of the Division of Cardiovascular Medicine within the Radcliffe Department of Medicine at the University of Oxford. Each participant will undergo 4 MRI scans; baseline, 3hours, 14 days and 42 days post intravenous iron infusion. Blood samples will also be collected at those timepoints for assessment of relevant heamatological and iron parameters. ;

Study Design

Related Conditions & MeSH terms

Iron-deficiency

Clinical Trial Details

NCT number	NCT05609318
Study type	Observational [Patient Registry]
Source	University of Oxford
Contact
Status	Recruiting
Phase
Start date	October 29, 2022
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04949165` - Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study	N/A
Terminated	`NCT03218384` - Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency	Phase 2
Active, not recruiting	`NCT03516734` - Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh	N/A
Completed	`NCT03572010` - Stable Iron Isotope Method in HIV+ and HIV- Children	N/A
Active, not recruiting	`NCT03703726` - Iron Absorption From Fortified Extruded Rice Using Different Extruding Temperatures.	N/A
Recruiting	`NCT05217836` - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Not yet recruiting	`NCT05395468` - Diagnosis of Iron Deficiency by Artificial Intelligence Analysis of Eye Photography.
Withdrawn	`NCT03800446` - Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood	N/A
Not yet recruiting	`NCT03353662` - Sub Regional Micronutrient Survey in Ethiopia
Completed	`NCT03819530` - Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study	N/A
Recruiting	`NCT04144790` - Impact of Iron Supplementation Treatment on Brain Iron Concentrations
Completed	`NCT03957057` - Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia	Phase 3
Completed	`NCT03642223` - Central and Peripheral Adiposity and Iron Absorption	N/A
Not yet recruiting	`NCT05407987` - Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)	Phase 3
Withdrawn	`NCT03873584` - Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
Enrolling by invitation	`NCT03897673` - Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas	N/A
Completed	`NCT04359368` - Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
Active, not recruiting	`NCT04778072` - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects	N/A
Enrolling by invitation	`NCT05750940` - Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency
Recruiting	`NCT05126901` - Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years	Phase 3